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Abstract 
 
Glycine receptor (GlyR) chloride channels mediate fast inhibitory neurotransmission in 
the spinal cord and brainstem. Four GlyR subunits (α1-3, β) have been identified in humans, and 
their differential anatomical distributions underlie a diversity of synaptic isoforms with unique 
physiological and pharmacological properties. To improve our understanding of these properties, 
we induced the formation of recombinant synapses between cultured spinal neurons and HEK293 
cells expressing GlyR subunits of interest plus the synapse-promoting molecule, neuroligin-2A. 
In the heterosynapses thus formed, recombinant α1β and α3β GlyRs mediated fast decaying 
inhibitory postsynaptic currents (IPSCs) whereas α2β GlyRs mediated slow decaying IPSCs. 
These results are consistent with the fragmentary information available from native synapses and 
single channel kinetic studies. As β subunit incorporation is considered essential for localizing 
GlyRs at the synapse, we were surprised that α1-3 homomers supported robust IPSCs with β 
subunit incorporation accelerating IPSC rise and decay times in α2β and α3β heteromers only. 
Finally, heterosynapses incorporating α1D80Aβ and α1A52Sβ GlyRs exhibited accelerated IPSC 
decay rates closely resembling those recorded in native synapses from mutant mice homozygous 
for these mutations, providing an additional validation of our technique. Glycinergic 
heterosynapses should prove useful for evaluating the effects of drugs, hereditary disease 
mutations or other interventions on defined GlyR subunit combinations under realistic synaptic 
activation conditions. 
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Introduction 
 
Glycine receptor (GlyR) chloride channels mediate fast inhibitory neurotransmission in 
the brainstem and spinal cord, and disruptions to their function underlie a range of disorders 
including chronic inflammatory pain (Lynch and Callister, 2006; Zeilhofer, 2005), hyperekplexia 
(Bode and Lynch, 2014), tinnitus (Wang et al., 2009), temporal lobe epilepsy (Eichler et al., 
2008) and neuropsychiatric disorders (Winkelmann et al., 2014). GlyRs are pentameric ligand-
gated ion channels comprizing either homomeric assemblies of α subunits or heteromeric 
assemblies of α and β subunits in either 2α:3β or 3α:2β stoichiometries (Durisic et al., 2012; 
Grudzinska et al., 2005; Yang et al., 2012). The β subunit is considered essential for clustering 
GlyRs at synapses due to its direct interaction with the cytoplasmic clustering protein, gephyrin 
(Fritschy et al., 2008; Kneussel and Loebrich, 2007; Meyer et al., 1995). In humans, four GlyR 
subunits (α1-3 and β) have been identified and their distribution varies both developmentally and 
regionally (Baer et al., 2009). This underlies a heterogeneity in inhibitory postsynaptic current 
(IPSC) kinetics and synaptic plasticity mechanisms that provide appropriately nuanced influences 
on network behavior in the central nervous system.  
Because it is often not possible to ascertain which GlyR subunits are present in a 
particular synapse, our understanding of the synaptic properties of different GlyR isoforms is 
incomplete. For example, although α3 immunoreactivity suggests it is strongly expressed in 
synapses on spinal nociceptive neurons (Harvey et al., 2004), there is doubt as to whether α3β 
GlyRs contribute significantly to the function of these synapses (Graham et al., 2011).  
A related issue is that it is difficult to validate the effects of drugs on defined GlyR 
isoforms under synaptic activation conditions. For example, compounds that potentiate α3-
containing GlyRs but do not affect other GlyRs are considered potential leads for analgesic 
development (Lynch and Callister, 2006; Zeilhofer, 2005). Because α1- and α3-containing GlyRs 
are both expressed in inhibitory synapses on spinal pain sensory neuron, with α3 possibly as the 
minor partner (Graham et al., 2011), any pharmacological effect of α3-specific drugs may be 
diluted by the presence of other isoforms. 
It has proved routinely possible to reconstitute GABAergic synapses between cultured 
GABAergic neurons (that provide the presynaptic terminals) and HEK293 cells that express the 
desired GABA-A subunits plus neuroligin 2 (NL2) (Dixon et al., 2014; Dong et al., 2007; Fuchs 
et al., 2013; Wu et al., 2012). We refer to these as ‘heterosynapses’. Postsynaptic NL2 is key to 
generating such synapses due to its ability to promote synapse formation by binding to trans-
synaptic neurexins (Lise and El-Husseini, 2006). Because NL2 is also important for glycinergic 
synapse maturation (Poulopoulos et al., 2009), we reasoned that it should be feasible to induce 
glycinergic heterosynapse formation between cultured spinal glycinergic neurons and HEK293 
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cells expressing NL2 plus the GlyR subunits of interest. In the present study, we show that this is 
indeed feasible and we employ this approach to characterize heterosynaptic IPSCs mediated by a 
variety of wild type and mutant GlyR subunit combinations.  
 
 
Materials and methods 
 
Cell culture and molecular biology 
Plasmid DNAs encoding the human α1 (pCIS), human α2 (pCIS), rat α3 (pcDNA3.1) and 
human β (pcDNA3.1) GlyR subunits were transfected into HEK293 cells via calcium phosphate-
DNA coprecipitation. We transfected α cDNA with β cDNA at different ratios from 1:1 to 1:100. 
Homomeric GlyRs were produced by transfecting α subunit only. In addition, the mouse NL2A 
splice variant (pNice) and rat gephyrin (pCIS) were co-transfected along with GlyR subunits, 
which facilitated the formation of heterosynapses. eGFP, which acted as expression marker was 
also transfected. The total amount of the final cDNA mixture per 35-mm petri dish was kept at 1 
– 2 μg. Site-directed mutagenesis was performed using the QuikChange mutagenesis kit, and the 
successful incorporation of mutation was confirmed by DNA sequencing. 
Primary cultures of spinal cord neurons were prepared as previously described (Hoch et 
al., 1989; Levi et al., 1998) from embryonic day 15 rat pups. Cells were plated at a density of 
~80000 cells per 18 mm poly-D-lysine coated coverslip in DMEM medium with 10% fetal 
bovine serum. After 24 hours, the plating medium was changed to Neurobasal medium 
supplemented with 2% B27 and 1% glutamax, and a second feed after one week replaced half of 
this medium. Neurons were grown for 1 – 4 weeks in vitro and the heterosynaptic co-cultures 
were prepared by directly introducing transfected HEK293 cells onto the primary neuronal 
cultures 1 – 3 days prior to recordings. 
 
Electrophysiology 
Whole-cell recordings were performed under voltage-clamp mode using a HEKA EPC10 
amplifier (HEKA Electronics, Lambrecht, Germany) and Patchmaster software (HEKA), at room 
temperature. Series resistance was routinely compensated to 60% of maximum and was 
monitored throughout the recording. Both spontaneous and action potential-evoked glycinergic 
IPSCs in HEK cells were recorded at a holding potential −60 mV and signals were filtered at 4 
kHz and sampled at 10 kHz.  Patch pipettes (4−8 MΩ resistance), made from borosilicate glass 
(GC150F-7.5, Harvard apparatus), were filled with an intracellular solution containing the 
following (in mM): 145 CsCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 EGTA and 2 MgATP, adjusted 
to pH 7.4 with NaOH. Cells were continuously perfused with extracellular solution comprizing 
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(in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 D-glucose, adjusted to pH 7.4 
with NaOH.  
In the pharmacological studies, lindane, strychnine or tricine (all from Sigma-Aldrich) 
were applied by bath perfusion. After waiting 2 min for drug effects to stabilize, we compared at 
least 3 min of spontaneous activity before and after drug application. 
  
Analysis 
Analyses of IPSC amplitude, 10−90% rise time, and decay time constant (single-
exponential) were performed using Axograph X (Axograph Scientific). Only cells with a stable 
series resistance of <25 MΩ throughout the recording period were included in the analysis. Single 
peak IPSCs with amplitudes of at least three times above the background noise were detected 
using a semiautomated sliding template. Each detected event was visually inspected and only 
well-separated IPSCs with no inflections in the rizing or decay phases were included. The 
kinetics of IPSCs were determined by averaging the selected currents. These averages from 
multiple recording days were then pooled to obtain group data. Statistical analysis and plotting 
were performed with Prism 5 (GraphPad Software). All data are presented as mean ± SEM. One-
way and two-way ANOVA were employed for multiple comparisons. Drug group comparisons 
were made using paired Student’s t-tests. For all tests, the number of asterisks corresponds to 
level of significance: *p < 0.05, **p < 0.01, ***p < 0.001and ****p < 0.0001.  
 
Results 
 
Establishing the conditions for reliable β subunit expression in heterosynapses 
As synaptic GlyRs are considered to comprise heteromers of α and β subunits (Lynch, 
2009), it is important to verify that αβ heteromeric GlyRs are predominantly expressed in our 
system. This is a particular concern given that a recent single channel study reported difficulty in 
reliably expressing heteromers of α3 and β subunits (Marabelli et al., 2013). As a negative control 
for βsubunit incorporation, we first tested whether α1, α2 or α3 subunits could form synaptic-like 
currents in the absence of the β subunit. These experiments involved transfecting HEK293 cells 
with the relevant α subunit plus NL2A and gephyrin. Sample recordings of IPSCs from HEK293 
cells expressing these constructs suggest markedly different decay kinetics for α1, α2 and α3 
GlyRs (Fig. 1A). Next, we transfected α and β cDNAs at different ratios (ranging from 1:1 to 
1:100) to identify the conditions required to achieve a high level of heteromeric receptor 
expression (Fig. 1B, C). In Fig. 1B, each data point represents the average of all IPSCs recorded 
from a single cell. Examples of IPSCs recorded from cells expressing the indicated heteromeric 
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GlyRs are shown in Fig. 1C. To pharmacologically verify β subunit incorporation into 
recombinant GlyRs, we applied 30 M lindane which completely inhibits homomeric GlyRs but 
does not affect  heteromeric GlyRs (Islam and Lynch, 2012). As expected, lindane completely 
inhibited IPSCs in cells expressing homomeric GlyRs but had no significant effect on those 
expressing heteromeric GlyRs (Fig. 1C, D). We also confirmed that heterosynaptic IPSCs 
mediated by all subunit combinations were completely inhibited by 10 M strychnine (e.g., Fig. 
1D), a potent but nonspecific GlyR antagonist (Legendre, 2001; Lynch, 2004). 
With increasing β subunit expression, we observed a trend toward faster IPSC decay time 
constants in α2 and α3-containing cells, but not in α1-containing cells (Fig. 1B). When α2 and β 
cDNAs were cotransfected at 1:1 and 1:10 ratios, decay time constants were broadly distributed, 
suggesting that the heterosynapses contained a mixed population of α2 homomeric and α2β 
heteromeric GlyRs. Lindane selectively eliminated the slower events, demonstrating that they 
were indeed mediated by homomeric α2 GlyRs (Fig. 2B). Lindane had no effect at α2:β 
transfection ratios of 1:50 and 1:100, suggesting that a reasonably pure population of heteromeric 
GlyRs had been attained. Co-expression with the β subunit also reduced decay time constants in 
HEK293 cells expressing the α3 subunit (Fig. 1A – C). However, the impact of increasing the 
proportion of β cDNA on mean decay time constants was less variable. With an α3:β transfection 
ratio of 1:10, all heterosynapses appeared to exclusively express α3β GlyRs (Fig. 1B). Thus, the 
optimal transfection ratios for generating heteromeric IPSCs were 1:50 for α2:β and 1:10 for α3:β 
(Fig. 1C). These ratios were used throughout the remainder of this study. 
We could not distinguish α1 from α1β GlyR-mediated IPSCs according to their decay 
kinetics (Fig. 1A – C). For the remainder of this study we employed a 1:50 transfection ratio for 
α1:β, consistent with previous studies that verified the incidence of heteromer formation by 
monitoring single channel conductance (Burzomato et al., 2004; Pitt et al., 2008).  
 
Kinetic properties of glycinergic heterosynapses  
We characterized the mean amplitudes, 10 – 90 % rise times and decay time constants of 
IPSCs mediated by recombinant α1, α2, α3, α1β, α2β and α3β GlyRs (Fig. 2). Intriguingly, 
heterosynapses incorporating α1β and α3β GlyRs exhibited similar IPSC characteristics (Fig. 2A), 
with mean amplitudes of 58.6 ± 6.4 pA and 53.7 ± 10.1 pA (p>0.05), mean 10 – 90 % rise times 
of 1.6 ± 0.1 ms and 2.0 ± 0.1 ms (p>0.05) and mean decay time constants of 7.2 ± 0.4 ms and 9.7 
± 0.5 ms (p>0.05), respectively. Conversely, α2β GlyR-mediated heterosynapses exhibited IPSCs 
with dramatically slower decay time constants (25.7 ± 1.5 ms) than those mediated by α1β or α3β 
GlyRs (Fig. 2A, right panel). As noted above, α1 is the only subunit that supports identical 
homomeric and heteromeric IPSC kinetics. In contrast, decay time constants measured from α2 
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and α3 homomeric heterosynapses were considerably longer than their heteromeric counterparts 
(Fig. 2A). A two-way ANOVA indicated that both α and β subunits had high significantly effects 
on current decay time constants (p < 0.0001). 
The event distribution histograms (Fig. 2B), which pooled the decay time constants of all 
individual events in six cells selected at random expressing the indicated homomeric and 
heteromeric GlyRs, confirms that the β subunit had little effect on the distribution of events in α1 
GlyR-containing heterosynapses. In contrast, incorporation of the β subunit into α2 and α3-
containing GlyRs shifted the distribution in the decay time constants to much lower values (Fig. 
2B). Finally, we found that 10 – 90 % rise times and decay time constants were not significantly 
correlated for any of the six GlyR isoforms (all linear correlation coefficients < 0.33). Together 
these results suggest that events mediated by each individual isoform cannot be segregated into 
different categories (e.g., synaptic vs. peri-synaptic). 
In summary, the kinetics of α1β and α3β GlyR-mediated IPSCs were similar to each other 
but faster than α2β GlyR-mediated IPSCs. In addition, the β subunit enhanced the decay rate of 
IPSCs mediated by α2- and α3-containing GlyRs only. 
 
Comparison of heterosynaptic and native synapses incorporating mutant α1 subunits 
Low (10 – 300 nM) zinc concentrations rapidly potentiate α1 GlyRs whereas higher 
concentrations (3 – 300 M) elicit a dose-dependent, slowly-developing inhibition (Bloomenthal 
et al., 1994). Zinc exerts broadly similar effects at all GlyR subtypes (Miller et al., 2005a) and the 
molecular determinants of both potentiation and inhibition are spatially distinct and have been 
well characterized (Grudzinska et al., 2008; Harvey et al., 1999; Laube et al., 1995; Laube et al., 
2000; Lynch et al., 1998; Miller et al., 2005a; Miller et al., 2005b; Nevin et al., 2003). Zinc is 
released from presynaptic glycinergic terminals upon nerve stimulation (Birinyi et al., 2001) and 
modulates glycinergic synaptic transmission in vivo by binding to and potentiating GlyRs. Given 
that the glycine concentration in the native synaptic cleft is saturating (Beato, 2008), the 
physiological effect of zinc is to prolong IPSC duration. The α1D80A mutation is one of several 
mutations known to selectively eliminate zinc potentiation (Hirzel et al., 2006; Lynch et al., 
1998). Consistent with this, a genetically modified mouse harbouring the homozygous α1D80A 
mutation exhibited rapidly decaying glycinegic IPSCs in adult hypoglossal motor neurons that 
predominantly express α1β GlyRs (Hirzel et al., 2006).  
We performed two experiments to evaluate whether endogenous zinc prolongs the 
duration of IPSCs in α1β GlyR-mediated heterosynapses. The first involved applying a 10 mM 
concentration of the zinc chelator, tricine. Fig. 3A displays sample recordings before and after 
tricine application, with the respective averaged, normalized IPSCs shown in Fig. 3B. As 
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summarized in Fig. 3C, 10 mM tricine significantly reduced the decay time constant (from 7.6 ± 
0.7 to 6.2 ± 0.8 ms; p < 0.01, paired t test; n = 6 cells), but had no effect on current amplitude 
(from 40.0 ± 6.3 to 37.1 ± 7.4 pA; p > 0.05, paired t test; n = 6 cells).  
We next compared the IPSCs recorded in vitro from homozygous α1D80A mice with those 
from heterosynapses incorporating recombinant α1D80Aβ GlyRs. Sample recordings from α1β and 
α1D80Aβ GlyRs are shown in Fig. 4A, with the respective averaged, normalized IPSCs shown in 
Fig. 4B. We observed no significant difference in amplitude but a dramatic reduction in decay 
time constants (α1β, 7.2 ± 0.4 ms vs. α1D80Aβ, 3.1 ± 0.3 ms; p < 0.0001; Fig. 4B, C). These results 
correspond remarkably well with those observed in native glycinergic IPSCs from α1D80A mice 
(see Fig. 7E and F in (Hirzel et al., 2006)), implying similar zinc concentrations in the respective 
synaptic clefts.  
The α1A52S mutation occurs naturally in the Spasmodic mouse where it reduces GlyR 
sensitivity to glycine, thereby accelerating IPSC deactivation and causing a hyperekplexia 
phenotype (Plested et al., 2007; Ryan et al., 1994). Consistent with this, IPSCs recorded from 
hypoglossal motor neurons of homozygous adult Spasmodic mice exhibit reduced amplitudes and 
accelerated decay rates (Graham et al., 2006; Graham et al., 2011). To assess whether the glycine 
concentration in the synaptic cleft of our heterosynapses is comparable with that found in native 
synapses, we investigated the effect of the A52S mutation. Figure. 4A shows examples of IPSCs 
recorded from heterosynapses containing α1A52Sβ GlyRs. As summarized in Fig. 4B and C, the 
mutation resulted in significant reductions in both IPSC amplitude (α1β, 58.6 ± 6.4 pA vs. 
α1A52Sβ, 33.8 ± 4.3 pA; p < 0.05) and decay time constants (α1β, 7.2 ± 0.4 ms vs. α1A52Sβ, 3.6 ± 
0.4 ms; p < 0.0001). As these changes closely mirror those of glycinergic IPSCs recorded in vitro 
from homozygous Spasmodic mice (Graham et al., 2006; Graham et al., 2011) they imply that a 
molecular perturbation affecting GlyR agonist sensitivity exerts similar effects in native synapses 
and heterosynapses.  
 
Comparison of heterosynaptic IPSC kinetics with the intrinsic kinetic properties of their 
component GlyRs 
 Table 1 provides a summary of the mean 10 – 90 % rise times and decay time constants 
for IPSCs mediated by all six wild type GlyR isoforms. Knowledge of the intrinsic activation and 
deactivation time courses of the GlyRs populating these heterosynapses would enable us to infer 
whether IPSC kinetics are determined by the intrinsic channel properties or by extrinsic factors 
such as the neurotransmitter concentration and time course. Intrinsic channel kinetic properties 
can be quantitated by single channel kinetic analysis. To date, this analysis has been employed to 
derive activation mechanisms for recombinant α1, α2 and α3 homomeric and α1β heteromeric 
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GlyRs (Beato et al., 2004; Burzomato et al., 2004; Krashia et al., 2011; Marabelli et al., 2013). 
Figure 5 presents examples of simulated IPSCs reconstituted using the optimal activation 
mechanism that was derived in each of these four studies. The relevant parameters from these 
simulations are also included in Table 1. For α1, α1β and α2 GlyRs, the IPSC decay rate and the 
intrinsic channel closing rate are in reasonable accord, but for α3 GlyRs the IPSC decay rate is 3-
fold slower than predicted by the intrinsic closing rate. In contrast, the rise times of 
heterosynaptic IPSCs are all much slower than the intrinsic channel activation rates, suggesting 
delayed activation by neurotransmitter in the synaptic cleft. 
 
Discussion  
 
Here we present a simple, robust method for inducing synapse formation between native 
glycinergic presynaptic terminals and HEK293 cells that recombinantly express the GlyR 
subunits of interest. This system was developed to provide a tractable means of evaluating the 
effects of drugs, hereditary disease mutations or other interventions on defined GlyR subunit 
combinations under realistic synaptic activation conditions. In the present study we sought to 
validate this method by comparing the influence of different GlyR subunits, both wild type and 
mutant, with information obtained by others in native glycinergic synapses.  
The α1β heteromer is the predominant adult synaptic GlyR isoform (Lynch, 2009). 
Allowing for variations in rise and decay times due to variations in dendritic filtering and 
intracellular chloride concentrations (Pitt et al., 2008), electrophysiological recordings of native 
glycinergic IPSCs in acute spinal cord or brain stem slices exhibit similar rise and decay times as 
observed in our heterosynapses. For example, in neurons of the rat anteroventral cochlear nucleus, 
where glycinergic synapses are somatic and thus not subject to dendritic filtering, the mean 10 – 
90 % rise time was 0.42 ms and the decay time course was fitted by the sum of two exponentials 
with time constants of 3.6 and 28.4 ms (Lim et al., 1999). In rat dorsal horn neurons, the mean 10 
– 90 % rise times and decay time constants were 0.76 and 10.2 ms, respectively (Takahashi et al., 
1992). In rat lumbar motor neurons the values were comparable at 0.79 and 7.1 ms, respectively 
(Beato, 2008). In adult hypoglossal motor neurons the 10 – 90 % rise times and decay time 
constants ranged between 0.6 – 1.8 and 4.9 – 7.7 ms, respectively (Graham et al., 2006; Hirzel et 
al., 2006; Muller et al., 2006; Singer et al., 1998). The α1β GlyR isoform is likely to predominate 
at all these synapses (Lynch, 2009). The mean decay time constant for α1β GlyRs measured in 
our heterosynapses (7.2 ms) fits well with these data, although our 10 – 90 % rise time (1.6 ms) is 
slower by a factor of two.  
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A striking finding was that α1- and α1β-mediated IPSCs exhibit identical kinetic profiles 
(Fig. 2). Since the IPSC decay time constants correspond well with the intrinsic channel 
deactivation time constants (Fig. 5, Table 1), we infer that both α1 and α1β GlyRs are activated 
by transmitter pulses briefer than their respective intrinsic channel closing rates. This implies that 
α1 GlyRs can mediate synaptic transmission as efficiently as α1β GlyRs. This is a surprising 
result given that the β subunit is considered essential for synaptic clustering via its specific 
interaction with gephyrin (Fritschy et al., 2008; Kneussel and Loebrich, 2007; Meyer et al., 1995). 
However, immunolabeling studies have found that GlyR α1 and α2 subunits can form small cell 
surface clusters independently of gephyrin (Meier et al., 2000) and an electrophysiological study 
has found evidence for IPSCs mediated by α1 homomeric GlyRs in embryonic zebrafish neurons 
(Legendre, 1997).  
The α2β GlyR predominates at glycinergic synapses in embryonic rat neurons (Lynch, 
2009). Glycinergic IPSCs in embryonic day 20 rat dorsal horn neurons exhibited a mean 10 – 90 % 
rise time of 0.91 ms and a mean decay time constant of 27 ms (Takahashi et al., 1992), with 
comparable values observed in embryonic zebrafish Mauthner neurons (Ali et al., 2000), 
perinatal rat hypoglossal neurons (Singer et al., 1998) and adult rat wide-field amacrine cells 
(Veruki et al., 2007) which are unusual for adult neurons in that they selectively express α2β 
GlyRs (Wassle et al., 2009).  The mean decay time constant recorded in the present study (26 ms) 
fits well with these data although our 10 – 90 % rise time (2.4 ms) is dramatically slower. The 
intrinsic deactivation properties of recombinant α2β GlyRs have yet to be investigated. 
The mean decay time constant of homomeric α2 GlyR-mediated IPSCs was very slow 
(~89 ms) but consistent with the intrinsic closing rate of these receptors (Fig. 5). Given this close 
correspondence, we infer that their respective channel closing rates governs the decay rates of 
recombinant α2 and α2β-mediated IPSCs. 
The α3β GlyR is generally sparsely expressed in vivo, although it is co-located with α1β 
GlyRs in glycinergic synapses on neurons in the superficial laminae of the spinal cord dorsal horn 
(Harvey et al., 2004). Although α3β-mediated IPSCs have yet to be recorded in isolation in native 
synapses, their kinetic properties appear indistinguishable from those of α1β GlyRs (Harvey et al., 
2004). This fits well with the results of the present study (Fig. 2).  
The rise and decay times of homomeric α3 GlyR-mediated IPSCs were significantly 
slower than those of α3β GlyRs (Fig. 2). Importantly, the homomeric decay time constants were 
also significantly slower than predicted by the intrinsic channel closing rate (Fig. 4). This 
suggests that the kinetic properties of α3-mediated IPSCs are governed by slow agonist access 
and removal. The fact that the rise times of α3β-mediated IPSCs are dramatically faster could 
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indicate an impact on receptor gating, or could imply they are located closer to synaptic release 
sites, which would be consistent with the role of the β subunit in gephyrin-dependent clustering.   
Chelation of synaptic zinc by tricine reduced the IPSC decay time constant from 7.6 ± 0.7 
to 6.2 ± 0.8 ms, consistent with a reduction in zinc potentiation. However, the D80A mutation, 
accelerated the decay rate by a much greater margin (7.2 ± 0.4 to 3.1 ± 0.3 ms). There are several 
possible reasons for this discrepancy. First, 10 mM tricine may not have completely chelated 
synaptic zinc. Second, the D80A mutation may have had a secondary accelerating effect on the 
intrinsic channel deactivation rate. Third, the complete elimination of zinc potentiation by the 
D80A mutation may have uncovered a high potency zinc inhibitory effect that may have 
contributed to the enhanced decay rate.  
 To summarise the main points, the decay rates of IPSCs mediated by α1β, α2β and α3β 
GlyRs in our heterosynapses are in close accord with those observed in native synapses 
comprizing the same subunits. These results, along with the close correspondence in the effects 
of the A52S and D80A mutations between native and heterosynapses, provide an important 
validation of our technique. However, IPSC rise times in our heterosynapses were relatively slow, 
implying either a greater distance between presynaptic release sites and postsynaptic GlyRs or a 
reduced neurotransmitter diffusion rate in the cleft (Nielsen et al., 2004). Our results also suggest 
that the decay rates of IPSCs mediated by α1 and α2 homomeric GlyRs are governed by the 
intrinsic channel closing rate, whereas those mediated by α3 homomeric GlyRs are governed by 
the slow rate of agonist access and removal. A possible explanation could be that α1, α1β and 
α3β GlyRs are clustered (or at least localized relatively close) to synaptic release sites and α3 
GlyRs are either unclustered or located further away from release sites. Finally, α2-containing 
GlyRs deactivate so slowly that it is difficult to infer their location although their slow rise times 
imply they are located a substantial distance from presynaptic terminals.  
  Specific GlyR isoforms are emerging as therapeutic targets for a range of disorders. For 
example, drugs that selectively potentiate α3-containing GlyRs are candidate lead compounds for 
chronic inflammatory pain (Lynch and Callister, 2006; Xiong et al., 2012; Zeilhofer, 2005). One 
of our motivations for developing the glycinergic heterosynaptic system was to validate the 
efficacy of α3 GlyR-specific drugs under synaptic activation conditions. It is difficult to do this in 
native synapses due to the co-localisation of α1β and α3β GlyRs in individual synapses on 
nociceptive neurons (Harvey et al., 2004), the similarity in their kinetic and pharmacological 
properties (Lynch, 2009) and the apparent low abundance of α3β versus α1β expression (Graham 
et al., 2011). The heterosynapse system not only avoids these problems but offers the opportunity 
of investigating GlyR clustering mechanisms, and the effects of posttranslational modifications 
 12 
(e.g., phosphorylation) and hereditary disease (e.g., hyperekplexia) mutations on the formation 
and function glycinergic synapses. 
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Table 1: GlyR kinetic properties 
 
 
 
Number of cells in parentheses 
na, not available  
 
 
  
 α1β α2β α3β α1 α2 α3 
10-90% 
Rise time (ms) 
Heterosynapses 
1.6 ± 0.1 
(n=13) 
2.7 ± 0.3 
(8) 
1.9 ± 0.1 
(20) 
1.7 ± 0.1 
(18) 
4.4 ± 0.3 
(13) 
2.6 ± 0.2 
(10) 
Simulation 0.1 na na 0.1 0.2 0.2 
Deactivation 
time constant 
(ms) 
Heterosynapses 7.2 ± 0.4 25.7 ± 1.5 9.7 ± 0.5 7.9 ± 0.5 88.8 ± 6.0 27.9 ± 2.0 
Simulation 10 na na 11 163 6.3 
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Figure Legends 
 
Figure 1. Homomeric and heteromeric GlyR-mediated IPSCs in heterosynapses. A. 
Representative recordings of glycinergic IPSCs in HEK293 cells expressing the indicated 
homomeric GlyRs at three different temporal resolutions. B. Distribution of decay time constants 
for IPSCs recorded with the indicated transfection ratios, showing the effects of incorporation of 
β subunit on IPSC decay times. Data were obtained in the absence and presence of extracellular 
lindane (LIN, 30 μM). Each data point represents the mean of all events recorded in a single cell. 
C. Representative glycinergic IPSCs recorded from HEK293 cells expressing the indicated 
heteromeric GlyRs. α and β GlyR cDNA were transfected at different ratios (1α:50β for α1β and 
α2β, 1α:10β for α3β) to minimize contamination by homomeric α receptors. D. Sample 
recordings illustrating the effect of lindane and strychnine on HEK293 cells expressing the 
indicated subunits. A transfection ratio of 1α:50β was used to generate α1β GlyRs. Mean results 
for lindane are shown in panel B. 
 
Figure 2. Comparison of the kinetics of heteromeric and homomeric GlyR-mediated IPSCs. A. 
Mean values for the amplitude, 10-90% rise time and decay time constant of IPSCs recorded 
from homomeric and heteromeric GlyRs (transfection ratios- 1α:50β for α1β and α2β, 1α:10β for 
α3β). Each data point represents the mean of all events recorded in a single cell. B. Distribution 
histograms of IPSC decay time constants plotted against normalized number of events (n=6 cells 
for each subtype). Inset shows homomer and heteromer averages for comparison (n>30 events for 
homomers; n>150 events for heteromers), normalized to peak amplitude. Scale bar, 50 ms. *p < 
0.05, **p < 0.01, ****p < 0.0001; #p < 0.05, ####p < 0.0001 relative to corresponding 
homomers. ns, not significant. 
 
Figure 3. Tricine shortens IPSC duration. A. Representative traces recorded from an α1β GlyR-
expressing cell before (black trace) and after 10 mM tricine (grey trace). B. Superimposed 
averaged traces of IPSCs (n>200 events) recorded before (black trace) and after tricine treatment 
(grey trace), normalized to peak amplitude. C. Mean IPSC amplitude and decay time constants in 
α1β GlyR-expressing cells before (filled black symbols) and after tricine treatment (unfilled grey 
symbols, n=6). ns, not significant. 
 
Figure 4. Effects of the D80A and A52S α1 subunit mutations on IPSCs mediated by α1β GlyRs 
A. Representative glycinergic IPSCs recorded from HEK cells expressing α1β, α1A52Sβ and 
α1D80Aβ GlyRs. B. Superimposed averaged glycinergic IPSCs (n > 150 events) mediated by α1β 
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(red), α1A52Sβ (orange) and α1D80Aβ (purple) GlyRs, normalized to peak amplitude. C. Averaged 
amplitude and decay time constants of α1β (n=13), α1A52Sβ (n=8) and α1D80Aβ (n=8) receptor-
mediated IPSCs.  
 
Figure 5. Ensemble current simulations based on intrinsic receptor activation properties. 
Simulated ensemble currents (shown as colored traces) for homomeric α1, α2, α3, and 
heteromeric α1β receptors were generated using functional activation mechanisms derived from 
single channel analysis. Accompanying the traces are the activation times (10-90%) and 
deactivation time constants from either a single, or weighted sum of two exponential fits. The 
simulations were generated in QuB (Nicolai and Sachs, 2013) for 1000 receptors in response to a 
1 ms application of agonist using ‘flip’ mechanisms. The mechanisms and rate constants 
employed in these simulations were obtained as follows: α1 homomeric GlyRs – scheme 5 from 
(Burzomato et al., 2004); α2 homomeric GlyRs – scheme 2 from (Krashia et al., 2011); α3 
homomeric GlyRs – scheme 3 from (Marabelli et al., 2013); α1β heteromeric GlyRs – scheme 5 
of (Burzomato et al., 2004). Corresponding mean recorded IPSCs (gray traces), reproduced from 
Fig. 2B, are included for comparison.  
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